Send to a Friend Font Size: Increase Decrease

ALVO and AMRX Related Headlines

Oct 6, 2025 08:00AM Kashiv Biosciences Announces Submission of Biologics License Application to U.S. FDA and Acceptance of Market Authorization Application by European Medicines Agency for ADL-018, a Proposed Biosimilar

ALVO and AMRX Related Press Releases

Oct 6, 2025 08:00AM Kashiv Biosciences Announces Submission of Biologics License Application to U.S. FDA and Acceptance of Market Authorization Application by European Medicines Agency for ADL-018, a Proposed Biosimilar

ALVO and AMRX Related SEC Filings